Literature DB >> 30852793

Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.

Marianna Trignani1, Angela Argenone2, Saide Di Biase3, Daniela Musio4, Anna Merlotti5, Stefano Ursino6, Ester Orlandi7, Domenico Genovesi3, Almalina Bacigalupo8.   

Abstract

BACKGROUND: This study, promoted by Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group, aimed to assess the current national practice of target volume delineation on a case of neck lymph node metastases from unknown primary evaluating inter-observer variability, in a setting of primary radiotherapy.
MATERIALS AND METHODS: A case of metastatic neck lymph node from occult primary was proposed to 17 radiation oncologists. A national reference RT center was identified and considered as benchmark. Participants were requested to delineate target volumes. A structured questionnaire was administered. A comparison between following parameters of the CTVs was performed: centroids distances, Dice similarity index (DSI), Jaccard index and mean distance to agreement (MDA). Volume expressed in cubic centimeters and CTVs cranio-caudal extension were evaluated.
RESULTS: Sixteen of 17 radiation oncologists recommended three CTVs dose levels. (CTV HD, CTV ID and CTV LD); CTV ID was not delineated by one of the participants and by the reference center. The distance between the reference centroid and the mean centroid of CTVs HD was 1.09 cm (0.36-3.99 cm); for CTV LD, a mean centroids distance of 2.45 (0.27-4.83 cm) was found, and for CTV HD, mean DSI is 0.48 and mean Jaccard index is 0.32 and MDA was 8.89 mm. CTV LD showed a mean DSI of 0.46, mean Jaccard index of 0.31 and MDA of 14.87 when compared to the reference.
CONCLUSION: Many aspects concerning treatment optimization of cervical nodes metastases from occult primary remain unclear, and we found a notable heterogeneity of global radiotherapy management reporting discordances both in target volume delineation and volume prescription.

Entities:  

Keywords:  Head and neck cancer; Inter-observer variability; Neck lymph node metastases; Radiotherapy; Target volume delineation; Unknown primary

Mesh:

Year:  2019        PMID: 30852793     DOI: 10.1007/s11547-019-01006-y

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  38 in total

1.  Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial.

Authors:  B Seddon; M Bidmead; J Wilson; V Khoo; D Dearnaley
Journal:  Radiother Oncol       Date:  2000-07       Impact factor: 6.280

2.  Epidemiology of unknown primary tumours.

Authors:  F Levi; V C Te; G Erler; L Randimbison; C La Vecchia
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

3.  Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research.

Authors:  Min Yao; Thanh Nguyen; John M Buatti; Kenneth J Dornfeld; Huaming Tan; Judith Wacha; John E Bayouth; Gerald H Clamon; Gerry F Funk; Russell B Smith; Kristi Chang; Henry T Hoffman
Journal:  Am J Clin Oncol       Date:  2006-12       Impact factor: 2.339

4.  Quality assurance in radiotherapy of breast cancer--variability in planning target volume delineation.

Authors:  M A Pitkänen; K A Holli; A T Ojala; P Laippala
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

5.  Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.

Authors:  A J van de Wouw; M L G Janssen-Heijnen; J W W Coebergh; H F P Hillen
Journal:  Eur J Cancer       Date:  2002-02       Impact factor: 9.162

Review 6.  Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?

Authors:  C Nieder; V Gregoire; K K Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

7.  Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology.

Authors:  C Grau; L V Johansen; J Jakobsen; P Geertsen; E Andersen; B B Jensen
Journal:  Radiother Oncol       Date:  2000-05       Impact factor: 6.280

8.  Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.

Authors:  Frank R Miller; Anand B Karnad; Tony Eng; David H Hussey; H Stan McGuff; Randal A Otto
Journal:  Head Neck       Date:  2008-01       Impact factor: 3.147

Review 9.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

10.  Improving the consistency in cervical esophageal target volume definition by special training.

Authors:  Patricia Tai; Jake Van Dyk; Jerry Battista; Edward Yu; Larry Stitt; Jon Tonita; Olusegun Agboola; James Brierley; Rashid Dar; Christopher Leighton; Shawn Malone; Barbara Strang; Pauline Truong; Gregory Videtic; C Shun Wong; Rebecca Wong; Youssef Youssef
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.